Literature DB >> 19434010

Disentangling contributions of reproductive tract infections to HIV acquisition in African Women.

Janneke H H M van de Wijgert1, Charles S Morrison, Joelle Brown, Cynthia Kwok, Barbara Van Der Pol, Tsungai Chipato, Josaphat K Byamugisha, Nancy Padian, Robert A Salata.   

Abstract

OBJECTIVE: : To estimate the effects of reproductive tract infections (RTIs) on HIV acquisition among Zimbabwean and Ugandan women.
METHODS: : A multicenter prospective observational cohort study enrolled 4439 HIV-uninfected women aged 18 to 35 attending family planning clinics in Zimbabwe and Uganda. Participants were interviewed, and tested for HIV and RTIs every 3 months for 15 to 24 months. They received HIV risk reduction counseling, male condoms, and treatment for curable RTIs.
RESULTS: : Despite HIV risk reduction counseling and regular screening and treatment for RTIs, the HIV incidence did not decline during the study. Positive HSV-2 serostatus at baseline (hazard ratio [HR] = 3.69, 95% confidence interval = 2.45-5.55), incident HSV-2 (HR = 5.35, 3.06-9.36), incident Neisseria gonorrhoeae (HR = 5.46, 3.41-8.75), and altered vaginal flora during the study (bacterial vaginosis [BV]: HR = 2.12, 1.50-3.01; and intermediate flora: HR = 2.02, 1.39-2.95) were independently associated with HIV acquisition after controlling for demographic and behavioral covariates and other RTIs (Treponema pallidum, Chlamydia trachomatis, Trichomonas vaginalis, and vaginal yeasts). For N. gonorrhoeae, C. trachomatis, T. vaginalis, and vaginal yeasts, the risk of HIV acquisition increased when the infection was identified at the visit before the HIV-detection visit or with the duration of infection. Population attributable risk percent (PAR%) calculations show that HSV-2 contributes most to acquisition of new HIV infections (50.4% for baseline HSV-2 and 7.9% for incident HSV-2), followed by altered vaginal flora (17.2% for bacterial vaginosis and 11.8% for intermediate flora).
CONCLUSIONS: : A substantial proportion of new HIV infections in Zimbabwean and Ugandan women are attributable to RTIs, particularly HSV-2 and altered vaginal flora.

Entities:  

Mesh:

Year:  2009        PMID: 19434010     DOI: 10.1097/OLQ.0b013e3181a4f695

Source DB:  PubMed          Journal:  Sex Transm Dis        ISSN: 0148-5717            Impact factor:   2.830


  69 in total

1.  Establishing and sustaining a healthy vaginal environment: analysis of data from a randomized trial of periodic presumptive treatment for vaginal infections.

Authors:  Jennifer E Balkus; Barbra A Richardson; Kishorchandra Mandaliya; James Kiarie; Walter Jaoko; Jeckoniah O Ndinya-Achola; Jeanne Marrazzo; Carey Farquhar; R Scott McClelland
Journal:  J Infect Dis       Date:  2011-07-15       Impact factor: 5.226

2.  Diagnosing Vaginal Infections: It's Time to Join the 21st Century.

Authors:  Barbara Van Der Pol
Journal:  Curr Infect Dis Rep       Date:  2010-05       Impact factor: 3.725

Review 3.  Inflammation and HIV Transmission in Sub-Saharan Africa.

Authors:  Rupert Kaul; Jessica Prodger; Vineet Joag; Brett Shannon; Sergey Yegorov; Ronald Galiwango; Lyle McKinnon
Journal:  Curr HIV/AIDS Rep       Date:  2015-06       Impact factor: 5.071

Review 4.  Vaginal microbiota and susceptibility to HIV.

Authors:  McKenna C Eastment; R Scott McClelland
Journal:  AIDS       Date:  2018-03-27       Impact factor: 4.177

Review 5.  Lessons from Suppressive Therapy and Periodic Presumptive Treatment for Bacterial Vaginosis.

Authors:  Jennifer E Balkus; Kayla A Carter; R Scott McClelland
Journal:  Curr Infect Dis Rep       Date:  2019-08-31       Impact factor: 3.725

6.  Prevalence of Sexually Transmitted Diseases and Risk Behaviors from the NIMH Collaborative HIV/STD Prevention Trial.

Authors:  David D Celentano; Kenneth H Mayer; Willo Pequegnat; Nadia Abdala; Annette M Green; H Hunter Handsfield; Tyler D Hartwell
Journal:  Int J Sex Health       Date:  2010

7.  Evaluation of the association between the concentrations of key vaginal bacteria and the increased risk of HIV acquisition in African women from five cohorts: a nested case-control study.

Authors:  R Scott McClelland; Jairam R Lingappa; Sujatha Srinivasan; John Kinuthia; Grace C John-Stewart; Walter Jaoko; Barbra A Richardson; Krista Yuhas; Tina L Fiedler; Kishorchandra N Mandaliya; Matthew M Munch; Nelly R Mugo; Craig R Cohen; Jared M Baeten; Connie Celum; Julie Overbaugh; David N Fredricks
Journal:  Lancet Infect Dis       Date:  2018-01-26       Impact factor: 25.071

8.  Type-specific cervico-vaginal human papillomavirus infection increases risk of HIV acquisition independent of other sexually transmitted infections.

Authors:  Karen K Smith-McCune; Stephen Shiboski; Mike Z Chirenje; Tsitsi Magure; Jennifer Tuveson; Yifei Ma; Maria Da Costa; Anna-Barbara Moscicki; Joel M Palefsky; Rudo Makunike-Mutasa; Tsungai Chipato; Ariane van der Straten; George F Sawaya
Journal:  PLoS One       Date:  2010-04-08       Impact factor: 3.240

9.  Characteristics of women screened for a contraceptive intravaginal ring study in Kisumu, Kenya, 2014.

Authors:  Eleanor McLellan-Lemal; Deborah A Gust; Roman Gvetadze; Melissa Furtado; Fredrick O Otieno; Mitesh Desai; Clement Zeh; Taraz Samandari; Beatrice Nyagol; Esther M Makanga
Journal:  Res J Womens Health       Date:  2016-07-06

Review 10.  The oral mucosa immune environment and oral transmission of HIV/SIV.

Authors:  Lianna F Wood; Ann Chahroudi; Hui-Ling Chen; Heather B Jaspan; Donald L Sodora
Journal:  Immunol Rev       Date:  2013-07       Impact factor: 12.988

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.